China-UK cooperation oup biological technology (Group) Co., Ltd.
OUP Biological Technology Co., Ltd. (Group) is a research and development, the country's first focus on Escherichia coli drug products production, sales as one of the veterinary drug manufacturing service providers. Company production base is located in industrial park of Anyang OUP Millennium ancient capital, the company a total investment of 50000000 yuan, covers an area of 80 mu, the first phase of the project completed powder, premix, disinfection liquid GMP standard production line. The two phase of the project is completed, the oral liquid herbal extracts such as high standard production line. The three phase of the project of feed additive and biological products such as high standard production line is about to start construction, after the completion of the nation's leading three fusion process production line will further improve the various categories of products distribution.
Focus to build China's lead brand is Escherichia coli drug OUP group since 8 years adhere to the brand development strategy, to 2012, Escherichia coli drug products accounted for 60% of the group's total sales, the initial formation of the Escherichia coli drug series products, product structure, comprehensive care to intestinal type auxiliary OUP group, is expected in 2015 Escherichia coli drug products sales will exceed 100000000 yuan.
In order to further enhance the core competitiveness of Escherichia coli drug China's first brand, since 2009, annual investment OUP group 3%-5% sales for product development, in foreign countries to the University of Liverpool (liverpool.uk) School of veterinary medicine for the window to absorb international advanced veterinary technology at home, the initial formation of the Henan agricultural University, Shandong Agricultural University, Huazhong Agricultural University, Henan Institute of animal husbandry economy of higher agricultural colleges Professor, graduate student 20 person R & D team, was declared the three patents, three class new veterinary drug has been approved to 2 countries, has been basically established the Chinese medicine and biological products such as prevention of colibacillosis, improve immunity, green no residual products as the main direction of research and development, set up a National Biotechnology R & D center on the development direction of the now.
In the future, we will strive to become China's most influential veterinary medicine R & D and production enterprises. OUP group will be adhering to the "unremitting self-improvement, social commitment" spirit of enterprise, and enterprise employees and competitors alternate win-win, full integration of animal husbandry resources, to expand the industrial chain, enhance the capital advantage, economies of scale, will be better, more health services in China animal husbandry industry, to bring more people to the rich!